Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unresolved issues in the genesis and management of multiple endocrine neoplasia type 2.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme - 1 Mar 1997

Gagel R F

Abstract excerpt

It has been slightly less than 3 years since mutations of the RET proto-oncogene were identified in multiple endocrine neoplasia type 2. The period since the initial report has been one of intense activity with a wide spectrum of mutations identified in exons 10, 11, 13, 14, 15 and 16 of this gene. Recent studies have provided experimental evidence for an activating effect of the exon 11 and 16 mutations. Two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Transformation, Neoplastic
Share to Drosophila Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to RET gene

Share to Mutation

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins

Share to Receptor Protein-Tyrosine Kinases

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 9137984
DOI: 10.1055/s-2007-979006

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unresolved issues in the genesis and management of multiple endocrine neoplasia type 2.PMID 9137984Read ↗

Clinical and molecular aspects of multiple endocrine neoplasia.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

Multiple endocrine neoplasias type 2B and RET proto-oncogene.Semantic proximity Read ↗

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.Semantic proximity Read ↗

A Two-Hit Model for Development of Multiple Endocrine Neoplasia Type 2B by RET MutationsSemantic proximity Read ↗

Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2 and the practice of molecular medicine.Semantic proximity Read ↗

Utility of RET mutation analysis in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

[Ret proto-oncogene mutations associated with type 2 multiple endocrine neoplasms (MEN 2). Clinical implications].Semantic proximity Read ↗

Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.